Web stats for Elephantheart - elephantheart.com
Welcome to Elephant Heart Jewelry. Our newly enhanced website features over 120 beautiful, hand-made necklaces, earrings and bracelets.
2.17
Rating by ClearWebStats
elephantheart.com is 1 decade 7 years 6 months old. This website has a #6,589,686 rank in global traffic. It has a com as an domain extension. This website has a Google PageRank of 3 out of 10. The DNS for Elephantheart is hosted at 216.70.104.203. While no active threats were reported recently by users, elephantheart.com is SAFE to browse.
Traffic Report of Elephantheart
| Daily Unique Visitors: | 73 |
| Daily Pageviews: | 146 |
Estimated Valuation
| Income Per Day: | $ 0.15 |
| Estimated Worth: | $ 8.95 |
Search Engine Indexes
| Google Indexed Pages: | Not Applicable |
| Yahoo Indexed Pages: | Not Applicable |
| Bing Indexed Pages: | 3 |
Search Engine Backlinks
| Google Backlinks: | Not Applicable |
| Bing Backlinks: | 1 |
Safety Information
| Google Safe Browsing: | No Risk Issues |
| Siteadvisor Rating: | Not Applicable |
| WOT Trustworthiness: | Not Applicable |
| WOT Privacy: | Not Applicable |
| WOT Child Safety: | Not Applicable |
Website Ranks & Scores
| Google Pagerank: |
|
| Alexa Rank: | 6,589,686 |
| Domain Authority: | Not Applicable |
Google Pagerank
PR 3 out of 10
PageSpeed Score
Score: 70on 100
Siteadvisor Rating
Where is elephantheart.com server located?
Social Engagement
| Facebook Shares: | 38 |
| Facebook Likes: | 14 |
| Facebook Comments: | 9 |
Page Resources Breakdown
Homepage Links Analysis
Similar Domain Names
These are similar domain names that may be used for typosquatting or phishing attacks. Always verify the URL before entering any sensitive information.
- elephantheart.co
- elephantheart.cm
- elephantheart.con
- elephantheart.net
- elephantheart.org
- eelephantheart.com
- ellephantheart.com
- eleephantheart.com
- elepphantheart.com
- elephhantheart.com
- elephaantheart.com
- elephanntheart.com
- elephanttheart.com
- elephanthheart.com
- elephantheeart.com
Website Inpage Analysis
| H1 Headings: | Not Applicable | H2 Headings: | Not Applicable |
| H3 Headings: | Not Applicable | H4 Headings: | Not Applicable |
| H5 Headings: | Not Applicable | H6 Headings: | Not Applicable |
| Total IFRAMEs: | Not Applicable | Total Images: | 19 |
| Google Adsense: | Not Applicable | Google Analytics: | UA-7998107-1 |
HTTP Header Analysis
Http-Version: 1.1
Status-Code: 200
Status: 200 OK
Date: Fri, 13 Jun 2014 07:42:52 GMT
Server: Apache
Expires: Thu, 19 Nov 1981 08:52:00 GMT
Cache-Control: no-store, no-cache, must-revalidate, post-check=0, pre-check=0
Pragma: no-cache
X-Powered-By: PleskLin
Connection: close
Transfer-Encoding: chunked
Content-Type: text/html; charset=utf-8;
Status-Code: 200
Status: 200 OK
Date: Fri, 13 Jun 2014 07:42:52 GMT
Server: Apache
Expires: Thu, 19 Nov 1981 08:52:00 GMT
Cache-Control: no-store, no-cache, must-revalidate, post-check=0, pre-check=0
Pragma: no-cache
X-Powered-By: PleskLin
Connection: close
Transfer-Encoding: chunked
Content-Type: text/html; charset=utf-8;
Domain Information for elephantheart.com
Domain Nameserver Information
DNS Record Analysis
| Host | Type | TTL | Extra |
|---|---|---|---|
| elephantheart.com | A | 43188 |
IP:216.70.104.203 |
| elephantheart.com | NS | 43200 |
Target:ns1.mediatemple.net |
| elephantheart.com | NS | 43200 |
Target:ns2.mediatemple.net |
| elephantheart.com | SOA | 43200 |
MNAME:ns1.mediatemple.net RNAME:dnsadmin.mediatemple.net Serial:2012052601 Refresh:10800 Retry:3600 Expire:1209600 Minimum TTL:43200 |
| elephantheart.com | MX | 43200 |
Priority:10 Target:mail.elephantheart.com |
Similarly Ranked Websites to Elephantheart
WHPacific
WHPacific, Inc. - Engineers | Architects | Surveyors | Planners
Oncotest- CRO in Preclinical Cancer Research Using Patient Derived Tumor Xenograft (PDX) models| gastric cancer, breast cancer, small cell lung cancer, pancreatic cancer, melanoma, leukemia - Oncotest
Using patient derived tumor xenograft (PDX) models, Oncotest as a CRO provides tailored preclinical solutions for the identification of the best anti-cancer drug candidates, target validation, and in-depth bioinformatics analyses.